cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
japr.editor@gmail.com
Editorial Address
Plot No. 105/42, Opposite electricity sub station, Changorabhata, Raipur (Chhattisgarh), India 492001
Location
,
INDONESIA
Journal of Applied Pharmaceutical Research
Published by Creative Pharma Assent
ISSN : -     EISSN : 23480335     DOI : 10.18231
Core Subject : Health,
Medicine & Pharmacology
Journal of Applied Pharmaceutical Research (JOAPR) is an official publication of Creative Pharma Assent (CPA). It is an open access, peer review online international journal. JOAPR is primarily focused on multiple discipline of pharmaceutical sciences (Pharmaceutics, Pharmaceutical Technology, Biopharmaceutics, Cosmetic Technology, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Herbal drugs/ formulations, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest) which publish quarterly. JOAPR also includes evaluation of pharmaceutical excipients & their practical application to research & industry based efforts. The aim of the scientific journal, JOAPR is to present a wide area for the current researchers to share their noble works and ideas in terms of the research papers, review articles and short communications. JOAPR only publish the original research works with a definite innovation and novelty after thorough reviewing. The paper must have a suitable and proper scientific background.
Arjuna Subject : -
Articles 4 Documents
 1 
Search results for , issue "Vol. 9 No. 3 (2021)" : 4 Documents clear
Rising Indian Clinical Trials Industry and Career Opportunities Biswas, Arghya
Journal of Applied Pharmaceutical Research Vol. 9 No. 3 (2021)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18231/j.joapr.2021.v9.i3.8-13

Abstract

The Indian clinical trials industry has seen stable growth over the past decades and especially since 2014 there has been a significant rise. With the current expected market growth rate, India has the potential to become one of the largest clinical trial hubs. The ministry of health had a very positive outlook towards the growth of the Indian clinical trial market; with the constant reformation of the regulatory guidance, the confidence of pharma companies to do trials in India is growing. The Covid-19 pandemic has caused mass public awareness about clinical trials and drug development process, this will increase acceptance and help to further promote the industry. This article provides an insight into the various drivers for the fast growth of the Indian clinical trials industry and at the same time discusses the numerous career opportunities the industry offers.
Current developments in prevention and treatment of candidiasis: A review Chakraborty, Prodipta; Pradhan, Darshan; Halder, Sudip; Bagchi, Arnab
Journal of Applied Pharmaceutical Research Vol. 9 No. 3 (2021)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18231/j.joapr.2021.v9.i3.21-25

Abstract

Invasive fungus infection affects about six people out of every 100,000 people each year. Only half of these infections are detected throughout the patient's lifetime, making it one of the most common causes of death among intensive-care patients. The low detection rate is due to the diagnostic work's complexity, which comprises clinical, radiographic, and microbiological results. Antimycotic drug-resistant fungi are on the rise all over the world. Guidelines for identifying and treating invasive fungous infections caused by Candida spp., Aspergillus spp., Mucorales, and Fusarium spp. are the topic of this review. In typical hospital care, intrusive fungous infections are frequently ignored. They must include it as a necessary component of antimicrobial stewardship programmes. There is also a great need for novel antimycotic medication classes to be developed
An overview on FDA-approved natural super disintegrants efficacy in a fast dissolving drug delivery system Pradhan, Darshan; Chakraborty, Prodipta; Halder, Sudip; Bagchi, Arnab
Journal of Applied Pharmaceutical Research Vol. 9 No. 3 (2021)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18231/j.joapr.2021.v9.i3.1-7

Abstract

FDTs are defined by the United States Food and Drug Administration (FDA) as a solid dosage form containing the therapeutic substance or when applied on the tongue, the active ingredient disintegrates quickly, usually within seconds. The goal of this study is to create a fast-dissolving tablet that uses natural disintegrants. Fast dissolving tablets have grown in popularity in the pharmaceutical industry in recent years. They have a quick disintegration activity that dissolves with saliva without the use of water when placed within the mouth. Furthermore, FDT aims to provide quick medication absorption, reduced toxicity, and higher drug bioavailability, and it is especially popular among geriatric and paediatric patients. Natural disintegrants, which are obtained from natural sources, have a number of advantages, including low cost, nontoxicity, biodegradability, environmental friendliness, and less adverse effects. As a result, it has been established that natural disintegrants are often safer than synthetic disintegrants. Natural disintegrants includes Chitin and chitosan, Guar gum, Gum karaya, Agar and treated agar, Fenugreek seed mucilage, Soy polysaccharide, Gellan gum, Mango peel pectin, Lepidium sativum mucilage, Plantago seed mucilage, Agele marmelos gum, Locust bean gum, Mangifera indica gum, Hibiscus rosa sinensis mucilage, Dehydrated banana powder.
Plants as pharmaceutical excipients in oral sustained drug delivery systems: A review Uwah, T O; Akpabio, E I; Effiong, Daniel
Journal of Applied Pharmaceutical Research Vol. 9 No. 3 (2021)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18231/j.joapr.2021.v9.i3.26-38

Abstract

Plants and their derivatives have contributed immensely to drug development for their application as medicinal agents or as excipients in preparation of new drug delivery systems. Their use keeps increasing by the day. The rich, yet-to-be fully tapped vegetation available in the African sub-region puts it with great potential to be the next global destination as sources for pharmaceutical excipient. This work reviews published articles on plants and derivatives that have been employed so far in modifying drug delivery. Published articles from databases of PubMed, science direct and google scholar were sourced. Obtained manuscripts were screened for relevance to the topic and currency from reading through the abstract and scanning the body of the work. Gums and mucilages as plant derivatives in their natural form or as changed forms have been well investigated for use in controlled drug delivery. Some of these have been as functional in modifying drug release as many commercially employed excipients in drug delivery. Many plants and plant-derived polymers are generally regarded as safe, easily cultivated, show good functionality as drug additives and can be modified to improve on any less desirable property. Taking advantage of these positive factors will open doors for optimal use of these naturally endowed pharmaceutical excipients

Page 1 of 1 | Total Record : 4

 1 

Filter by Year

2021 2021


Reset
Filter By Issues
All Issue Vol. 13 No. 4 (2025) Vol. 13 No. 3 (2025) Vol. 13 No. 2 (2025) Vol. 13 No. 1 (2025) Vol. 12 No. 6 (2024) Vol. 12 No. 5 (2024) Vol. 12 No. 4 (2024) Vol. 12 No. 3 (2024) Vol. 12 No. 2 (2024) Vol. 12 No. 1 (2024) Vol. 11 No. 5 (2023) Vol. 11 No. 4 (2023) Vol. 11 No. 3 (2023) Vol. 11 No. 2 (2023) Vol. 11 No. 1 (2023) Vol. 10 No. 4 (2022) Vol. 10 No. 3 (2022) Vol. 10 No. 2 (2022) Vol. 10 No. 1 (2022) Vol. 9 No. 4 (2021) Vol. 9 No. 3 (2021) Vol. 9 No. 2 (2021) Vol. 9 No. 1 (2021) Vol. 8 No. 4 (2020) Vol. 8 No. 3 (2020) Vol. 8 No. 2 (2020) Vol. 8 No. 1 (2020) Vol. 7 No. 4 (2019) Vol 7 No 3 (2019) Vol. 7 No. 3 (2019) Vol 7 No 2 (2019) Vol. 7 No. 2 (2019) Vol 7 No 1 (2019) Vol. 7 No. 1 (2019) Vol 6 No 4 (2018) Vol. 6 No. 4 (2018) Vol 6 No 3 (2018) Vol. 6 No. 3 (2018) Vol 6 No 2 (2018) Vol. 6 No. 2 (2018) Vol 6 No 1 (2018) Vol. 6 No. 1 (2018) Vol. 5 No. 4 (2017) Vol 5 No 4 (2017) Vol 5 No 3 (2017) Vol. 5 No. 3 (2017) Vol 5 No 2 (2017) Vol. 5 No. 2 (2017) Vol. 5 No. 1 (2017) Vol 5 No 1 (2017) Vol 4 No 4 (2016) Vol. 4 No. 4 (2016) Vol. 4 No. 3 (2016) Vol 4 No 3 (2016) Vol. 4 No. 2 (2016) Vol 4 No 2 (2016) Vol 4 No 1 (2016) Vol. 4 No. 1 (2016) Vol 3 No 4 (2015) Vol. 3 No. 4 (2015) Vol. 3 No. 3 (2015) Vol 3 No 3 (2015) Vol 3 No 2 (2015) Vol. 3 No. 2 (2015) Vol. 3 No. 1 (2015) Vol 3 No 1 (2015) Vol 2 No 4 (2014) Vol. 2 No. 4 (2014) Vol. 2 No. 3 (2014) Vol 2 No 3 (2014) Vol. 2 No. 2 (2014) Vol 2 No 2 (2014) Vol 2 No 1 (2014) Vol. 2 No. 1 (2014) Vol. 1 No. 1 (2013) Vol 1 No 1 (2013) More Issue